Login
From:
Drug Discovery and Development
(Uncensored)
subscribe
Eli Lilly acquires Verve Therapeutics in $1.3 billion deal, validating gene editing for heart disease
https://www.drugdiscoverytrends.com/eli-lilly-acquires-verve-therapeutics-in-1-3-billion-deal-validating-gene-editing-for-heart-disease/
links
backlinks
Tagged with:
acquisition
cardiovascular disease
eli lilly
1.3 billion
base editing
contingent value right
Eli Lilly and Co. has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion, in a move that bolsters Lilly's push into gene editing for cardiovascular conditions and signals renewed confidence in the sector.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
